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A B S T R A C T
Background: Extreme hyperpyrexia (T > 41.5 8C [106.7 8F]) represents an unusual challenge in critical
care medicine, which has historically resulted in 100% mortality when it is secondary to the thermal
dysregulation seen in ‘‘quad fever.’’
Purpose: A novel approach to this disorder, utilizing a protocol driven external cooling device for
therapeutic hypothermia to reestablish normothermia, and survival is described.
Patient sample: We present the case of a 20 year old male who developed quad fever with extreme
hyperpyrexia (T = 42.1 8C [107.8 8F]).
Results: He was successfully treated, and survived utilizing an external cooling device based
hypothermia protocol. The current literature on this topic is reviewed.
Conclusion: While ‘‘quad fever’’ has an extremely high mortality, with the success in this pilot case, early,
aggressive use of an external cooling device based hypothermia protocol is advocated.
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While fever is common in hospitalized patients, extreme
hyperpyrexia, namely a temperature >42.1 8C [106.7 8F], is rare.
Among the relatively few causes of this phenomenon in hospital-
ized patients are malignant neuroleptic syndrome, cholinesterase
deﬁciency, drug fever and central fevers [1,2]. In a spinal cord
injury (SCI) patient, central fever may be due to ‘‘quad fever.’’ By
deﬁnition, ‘‘quad fever’’ is an extreme elevation in body core
temperature beyond 40.8 8C (105.4 8F) in a patient with SCI. [3] The
SCI patient particularly at high risk for the development of
hyperpyrexia is the one with a high cervical spine injury that is
quadriplegic, although it has been described in the paraplegic with
a mid-level or higher thoracic spine injury [4,5]. These cases of
hyperthermia usually have no identiﬁed cause other than the
autonomic dysfunction seen in the SCI patient. Severe autonomic
dysfunction can result in thermodysregulation, as well as
neurogenic shock, cardiac dysrhythmias (bradycardia and even
asystole), orthostatic hypotension, autonomic dysreﬂexia, and
hyperhidrosis. [3] The incidence of ‘‘quad fever’’ is rare, and the
highest reported temperature is 44 8C (111.2 8F) [6]. Among the* Corresponding author at: Winthrop University Hospital, Department of Surgery,
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1572-3461  2013 Elsevier Ltd. Open access under the Elsevier OA license.quadriplegic patients who developed hyperpyrexia, it has histori-
cally proved fatal. Although antipyretics are commonly used to
treat fever of different etiologies and are generally efﬁcacious, they
are ineffective in treating the hyperpyrexia seen in this severe
autonomic thermodysregulation [3,4].
2. Case presentation
A 20 year-old male was admitted to the emergency department
after suffering a gunshot wound to the neck. This trauma resulted
in a midcervical level lesion with complete quadriplegia (ASIA
grade A, GCS = 15). The patient experienced new onset hyperpy-
rexia ten days after admission noted to be 41.1 8C (106 8F)
measured via a temperature sensing Foley catheter. He had no
prior signiﬁcant medical or surgical history. Despite treatment
with broad-spectrum antibiotics, pancultures, and consultation
with an infectious disease specialist, no infectious aetiology was
found. Review of his medications ruled out the possibility of a
drug-induced fever, and thyrotoxicosis was excluded by thyroid
function tests as well. The diagnosis of ‘‘quad fever’’ was made as a
diagnosis of exclusion retrospectively. Of note, he did not
experience any other manifestations of autonomic instability,
during the hyperpyrexia, or subsequently.
In an effort to lower his body temperature, pharmacologic
efforts included single doses of the following: intravenous
ibuprofen (Caldolor) 800 mg, oral acetaminophen 650 mg, as well
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physical measures included utilization of an external cooling
blanket, and multiple ice packs to the axillary and inguinal regions.
Despite all of the above measures, the patient’s body temperature
continued to rise, peaking at 42.1 8C (107.8 8F). After this
temperature spike, the patient’s heart rate was 138 beats per
minute and his blood pressure was 118/51 mm Hg.
At that point, our hospital’s hypothermia protocol utilizing an
external cooling pad device (Arctic Sun 2000) was implemented to
treat the hyperpyrexia as all previous treatments had failed to
control the temperature. His blood chemistry was signiﬁcant for
anaemia, an increase in his blood urea nitrogen likely secondary to
hypovolemia from insensible water loss, a mild elevation in the
troponin, and leukocytosis during the hyperpyrexic event. Twelve
hours after his maximum temperature spike, creatinine phospho-
kinase (CPK) level increased from 570 m/L to 3016 m/L. Within 5 h,
normothermia was achieved (Fig. 1) and he was kept at 37 8C
(98.6 8F) via the external cooling pad device for a full 24 h to
reestablish normothermia. The patient did not develop hyperpy-
rexia again during his hospitalization, survived without additional
neurologic injury, and was discharged to a rehab facility.
3. Discussion
Hypothalamic regulation autonomically controls body temper-
ature [1,5]. These regulatory centres are able to maintain
normothermia by utilizing cooling mechanisms to counteract
endogenous heat production [7]. When patients suffer high
cervical lesions, these regulatory centres may be disrupted,
resulting in a pathophysiological response to temperature control
[3]. Also, reduced blood ﬂow to the brain, a side effect of
hyperpyrexia itself, can damage central homeostatic mechanisms,
further compromising the efﬁcacy of cooling processes [8–10].
These effects can result in excessive heat production and increased
body temperature.
Cellular damage has been documented to occur upon exposure
to temperatures of 40–41 8C (104–105.8 8F). The effects include
protein denaturation, growth inhibition, and alterations in signal
transduction [8]. Hyperthermia has known effects on normal
organs including lesions in the central nervous system, kidney,
heart, liver, and bone marrow. Systemic effects include coagulo-
pathy, hypovolemia, acute tubular necrosis, abnormal liver
enzymes which may progress to severe liver necrosis, brain
oedema, extensive neuronal loss and gliosis, and intraparenchymal
haemorrhage in the adrenal gland. Haematological effects include
bone marrow suppression resulting in thrombocytopenia, as well
as intravascular hemolysis [9,10].
Our patient developed the hyperpyrexia ten days into his
hospital admission which is consistent with previously describedFig. 1. Temperature chart of the hyperpyrexic event. Normothermia achieved
within 5 h of initiation of the noninvasive cooling device protocol.cases in which ‘‘quad fever’’ developed within the ﬁrst two
weeks after trauma [3,4]. Therapeutic hypothermia protocols
are utilized to induce lower body temperatures after cardiac
arrest for neuroprotection, and to treat intractable intracranial
hypertension.
However, a hypothermic protocol is not routinely used to
treat hyperpyrexia. Literature search revealed only one previous
study where an external cooling device (Arctic Sun 20001) was
used to achieve normothermia in a hyperthermic patient [7].
Although the protocol was successful in inducing lower body
temperatures via this noninvasive device, it was not used to
treat ‘‘quad fever,’’ but rather neuroleptic malignant syndrome.
There is one report of two cases which used an invasive
endovascular cooling device to treat ‘‘quad fever.’’ In one of the
cases, the device normalized the patient’s body temperature
within 5 h, but the patient later died as a result of catheter-
related deep vein thrombosis, a complication known to occur
with invasive intravenous cooling devices. In the second patient,
the cooling device was unsuccessful in controlling body
temperature [11].
4. Conclusion
Due to the high mortality associated with extreme hyperpy-
rexia due to ‘‘quad fever’’ we advocate early aggressive
treatment. With the failure of antipyretic medications in these
patients, we advocate the use of a hypothermia protocol for
aggressive, early treatment of these critically ill patients. To the
best of our knowledge, we believe this to be the ﬁrst reported
case of use of a noninvasive cooling device for the treatment of
extreme hyperpyrexia (42.1 8C [107.8 8F]) in a quadriplegic
patient. Unlike the previous report utilizing an invasive,
endovascular device, we found a noninvasive cooling device
based protocol to be safe and efﬁcacious at achieving
normothermia in our case.
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